Evaluation of the Optimal Technique for Determination of Renal Function of Critically Ill Patients

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00117390
First received: June 30, 2005
Last updated: December 19, 2007
Last verified: December 2007
  Purpose

The purpose of this study is to evaluate the optimal technique for determination of the renal function of critically ill patients.


Condition Intervention
Renal Function
Critical Illness
Procedure: Measurement of inulin clearance

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Evaluation of the Optimal Technique for Determination of the Renal Function of Critically Ill Patients

Resource links provided by NLM:


Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Comparison of the determination of the renal function by other means than the golden standard, inulin clearance

Estimated Enrollment: 50
Study Start Date: June 2004
Study Completion Date: October 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Over 18 years old
  • Intensive care patient
  • Given informed consent
  • Arterial infusion
  • A bladder catheter

Exclusion Criteria:

  • Diurese < 400 mL/d
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00117390

Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Eric Hoste, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00117390     History of Changes
Other Study ID Numbers: 2004/101
Study First Received: June 30, 2005
Last Updated: December 19, 2007
Health Authority: Belgium: Federal Agency for Medicines and Health Products, FAMHP

Additional relevant MeSH terms:
Critical Illness
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on April 16, 2014